Edward Rebar

Edward John Rebar is an American biologist. Rebar is the senior vice president and chief technology officer of Sangamo Therapeutics. He researches the use of zinc fingers as a protein platform.

Edward Rebar
Born
Edward John Rebar
Alma mater
Known forZinc finger protein platform
Scientific career
Fields
  • Structural biology
  • Biophysics
InstitutionsSangamo Therapeutics
ThesisSelection studies of zinc finger-DNA recognition (1997)
Doctoral advisorCarl Pabo

Education

Edward John Rebar earned a Bachelor of Science in biochemistry from Rutgers University. He completed a Doctor of Philosophy in biophysics and structural biology from Massachusetts Institute of Technology. His 1997 dissertation was titled Selection studies of zinc finger-DNA recognition. His doctoral advisor was Carl Pabo.[1] Rebar worked as a post-doctoral fellow at the University of California, Berkeley.[2]

Career

Rebar joined Sangamo Therapeutics in 1998. He worked on the zinc finger protein platform developed by the company. In 2018, Rebar replaced Michael C. Holmes as the senior vice president and chief technology officer of Sangamo.[2][3]

gollark: Oh, ID checks.
gollark: IDS?
gollark: Copy protection is impossible.
gollark: So use base85.
gollark: I was KILLED BY THE PREIDDEENT!

References
  1. Rebar, Edward John (1997). Selection studies of zinc finger-DNA recognition (Thesis).
  2. "Sangamo Therapeutics appoints Edward Rebar as senior vice president". Post Online Media. Richmond, California. July 16, 2018. Retrieved October 1, 2018.
  3. Hale, Conor (July 20, 2018). "Chutes & Ladders: Sangamo loses another top executive". FierceBiotech. Retrieved February 11, 2019.
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.